09:00 – SPOTLIGHT ROUNDTABLES

Secure your seat at the table and ensure you’re part of the conversation. With your peers, debate the challenges, discuss the opportunities and discover the solutions to the most pressing challenges within cell and gene therapies.  

ROUNDTABLE 1: OPERATIONAL EXCELLENCE WITHIN MANUFACTURING; COMMERCALISATION VS COST  

Moderator: Frank Thielmann, Head Lean – Global Operational Excellence, Takeda

ROUNDTABLE 2: THE IMPORTANCE OF BRAND STRATEGY & DEVELOPMENT IN YOUR COMMERCIALISATION JOURNEY 

Moderator: Steve Bloodworth, Head of Commercial Partnering & Martech Deployment, AstraZeneca

ROUNDTABLE 3: RAW & STARTING MATERIALS FOR ATMP’S: ENSURING QUALITY, RELIABILITY AND SPEED 

Moderators:

Alexandre Reeber, CEO, Core Biogenesis

Daniel Cermeno, Product Manager, Core Biogenesis 

ROUNDTABLE 4: CREATING A SUSTAINABLE CELL & GENE THERAPY COMPANY

Moderator: Joel Eichmann, Co-founder, Green Elephant Biotech

ROUNDTABLE 5: CHALLENGE AND BARRIERS TO MOVE FROM 2D TO STIRRED 3D SYSTEMS

Moderator: Moderator: Giovanni Lorenzon, Bioprocess Specialist, Eppendorf

ROUNDTABLE 6: PATIENT ENGAGEMENT DURING CLINICAL DEVELOPMENT: KEEPING THE ‘CUSTOMER’ IN MIND 

Moderator: Kai Pinkernell, Chief Medical Officer, Glycostem

10:00 – ROUND TABLE INSIGHT SHARING:

Learn & benefit from shared key takeaways from the other round table discussions taking place